- Home
- GETY vs LYEL Comparison
GETY vs LYEL Comparison
Compare GETY & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GETY | LYEL |
|---|---|---|
| Founded | 1995 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.0M | 745.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GETY | LYEL |
|---|---|---|
| Price | $1.31 | $24.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $5.01 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 1.7M | 138.8K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $946,327,000.00 | $41,000.00 |
| Revenue This Year | $2.53 | N/A |
| Revenue Next Year | $3.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.10 | N/A |
| 52 Week Low | $1.20 | $7.65 |
| 52 Week High | $3.21 | $45.00 |
Technical Indicators
Market Signals| Indicator | GETY | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 39.40 |
| Support Level | $1.26 | $22.38 |
| Resistance Level | $1.34 | $25.12 |
| Average True Range (ATR) | 0.06 | 2.44 |
| MACD | 0.01 | -1.11 |
| Stochastic Oscillator | 64.10 | 10.05 |
Price Performance
Historical ComparisonAbout GETY Getty Images Holdings Inc.
Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.